Reactivating RB via CDK2 Inhibition Reduces Lung Cancer Aggressiveness

Cancer Discovery- United States

doi 10.1158/2159-8290.cd-rw2019-072

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer Through the Centrosomal Protein CP110

Cancer Research
Cancer ResearchOncology
2015English

Iodine‑125 Interstitial Brachytherapy Reduces Tumor Growth via Warburg Effect Inhibition in Non‑small Cell Lung Cancer A549 Xenografts

Oncology Letters
Cancer ResearchOncology
2018Tagalog

Immune Reprogramming via PD-1 Inhibition Enhances Early-Stage Lung Cancer Survival

JCI insight
Medicine
2018Luxembourgish

Cdk2-Dependent Inhibition of P21 Stability via a C-Terminal Cyclin-Binding Motif

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor

PLoS ONE
Multidisciplinary
2010English

Ampelopsin Reduces the Migration and Invasion of Ovarian Cancer Cells via Inhibition of Epithelial-To-Mesenchymal Transition

Oncology Reports
MedicineCancer ResearchOncology
2014English

miR-22 Inhibition Reduces Hepatic Steatosis via FGF21 and FGFR1 Induction

JHEP Reports
2020English

Up-Regulated Linc00472 Suppresses Development of Lung Cancer Cell via Inhibition of MiR-196b-5p

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2019English

Structure, Function, and Inhibition of Drug Reactivating Human Gut Microbial Β-Glucuronidases

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy